| Characterization of spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival Y Masugi, T Abe, A Ueno, Y Fujii-Nishimura, H Ojima, Y Endo, Y Fujita, ... Modern pathology 32 (10), 1495-1507, 2019 | 97 | 2019 |
| KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study Y Nakano, M Kitago, S Matsuda, Y Nakamura, Y Fujita, S Imai, M Shinoda, ... British journal of cancer 118 (5), 662-669, 2018 | 81 | 2018 |
| Usefulness of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant … T Yokose, M Kitago, Y Matsusaka, Y Masugi, M Shinoda, H Yagi, Y Abe, ... Cancer medicine 9 (12), 4059-4068, 2020 | 24 | 2020 |
| Combination of KRAS and SMAD4 mutations in formalin‐fixed paraffin‐embedded tissues as a biomarker for pancreatic cancer T Yokose, M Kitago, S Matsuda, Y Sasaki, Y Masugi, Y Nakamura, ... Cancer science 111 (6), 2174-2182, 2020 | 19 | 2020 |
| A novel online calculator to predict risk of microvascular invasion in the preoperative setting for hepatocellular carcinoma patients undergoing curative-intent surgery Y Endo, L Alaimo, HA Lima, Z Moazzam, F Ratti, HP Marques, ... Annals of surgical oncology 30 (2), 725-733, 2023 | 18 | 2023 |
| High risk pathogens and risk factors for postoperative pancreatic fistula after pancreatectomy; a retrospective case-controlled study K Abe, M Kitago, M Shinoda, H Yagi, Y Abe, G Oshima, S Hori, T Yokose, ... International Journal of Surgery 82, 136-142, 2020 | 18 | 2020 |
| Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic … Y Endo, M Kitago, K Aiura, M Shinoda, H Yagi, Y Abe, G Oshima, S Hori, ... World Journal of Surgical Oncology 17, 1-8, 2019 | 18 | 2019 |
| Higher tumor burden status dictates the impact of surgical margin status on overall survival in patients undergoing resection of intrahepatic cholangiocarcinoma Y Endo, K Sasaki, Z Moazzam, HA Lima, L Alaimo, A Guglielmi, ... Annals of Surgical Oncology 30 (4), 2023-2032, 2023 | 15 | 2023 |
| Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma Z Moazzam, HA Lima, L Alaimo, Y Endo, CF Shaikh, F Ratti, HP Marques, ... Surgery 172 (5), 1448-1455, 2022 | 15 | 2022 |
| Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling Y Endo, M Fujimoto, N Ito, Y Takahashi, M Kitago, M Gotoh, N Hiraoka, ... Journal of Cancer Research and Clinical Oncology 147, 1341-1354, 2021 | 14 | 2021 |
| Quality of ChatGPT responses to questions related to liver transplantation Y Endo, K Sasaki, Z Moazzam, HA Lima, A Schenk, A Limkemann, ... Journal of Gastrointestinal Surgery 27 (8), 1716-1719, 2023 | 13 | 2023 |
| Disparities in socioeconomic factors mediate the impact of racial segregation among patients with hepatopancreaticobiliary cancer MM Munir, S Woldesenbet, Y Endo, Z Moazzam, HA Lima, L Azap, ... Annals of Surgical Oncology 30 (8), 4826-4835, 2023 | 13 | 2023 |
| Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma MM Munir, L Alaimo, Z Moazzam, Y Endo, HA Lima, C Shaikh, A Ejaz, ... Journal of surgical oncology 127 (1), 81-89, 2023 | 13 | 2023 |
| Disparities in NCCN guideline-compliant care for patients with early-stage pancreatic adenocarcinoma at minority-serving versus non-minority-serving hospitals HA Lima, L Alaimo, Z Moazzam, Y Endo, S Woldesenbet, E Katayama, ... Annals of Surgical Oncology 30 (7), 4363-4372, 2023 | 11 | 2023 |
| TBS-based preoperative score to predict non-transplantable recurrence and identify candidates for upfront resection versus transplantation for hepatocellular carcinoma HA Lima, Z Moazzam, Y Endo, L Alaimo, C Shaikh, MM Munir, V Resende, ... Annals of surgical oncology 30 (6), 3363-3373, 2023 | 11 | 2023 |
| Necessity for primary care immediately after the March 11 tsunami and earthquake in Japan S Kohsaka, Y Endo, I Ueda, J Namiki, K Fukuda Archives of internal medicine 172 (3), 290-291, 2012 | 11 | 2012 |
| Racial Segregation among patients with cholangiocarcinoma—impact on diagnosis, treatment, and outcomes MM Munir, S Woldesenbet, Y Endo, HA Lima, L Alaimo, Z Moazzam, ... Annals of Surgical Oncology 30 (7), 4238-4246, 2023 | 10 | 2023 |
| Mediators of county‐level racial and economic privilege in cancer screening MM Munir, S Woldesenbet, L Alaimo, Z Moazzam, HA Lima, Y Endo, ... Journal of surgical oncology 127 (7), 1212-1222, 2023 | 10 | 2023 |
| Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma Y Endo, HA Lima, L Alaimo, Z Moazzam, Z Brown, CF Shaikh, F Ratti, ... HPB 25 (3), 353-362, 2023 | 10 | 2023 |
| Tumor burden score and serum alpha-fetoprotein subclassify intermediate-stage hepatocellular carcinoma HA Lima, Y Endo, L Alaimo, Z Moazzam, MM Munir, C Shaikh, V Resende, ... Journal of Gastrointestinal Surgery 26 (12), 2512-2521, 2022 | 10 | 2022 |
Timothy M. PawlikChair, Department of Surgery, The Ohio State University在 osumc.edu 的电子邮件经过验证
